Ilumina (ILMN) is down 3.7% after Leerink Swann downgrades the company to Market Perform, and...

|By:, SA News Editor

Ilumina (ILMN) is down 3.7% after Leerink Swann downgrades the company to Market Perform, and lowers its valuation range to $53-$57. The firm thinks the growth of Ilumina's high-end HiSeq genetic sequencing systems is decelerating over the short-term, and think NIH budget cuts could also hurt the company.